K2 Bio Partners III L.P. is a venture capital fund based in Grand Cayman, Cayman Islands. According to its most recent Form D, filed May 6, 2025, it has sold $30,500,000 of interests to 3 investors since its first sale in Apr 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Rui Zhang; Keyi Chen; K2 Bio Partners III GP Limited.
- Total raised
- $30,500,000Cumulative sales reported on Form D
- Investors
- 3
- First sale
- Apr 24, 2025
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Rui Zhang; Keyi Chen; K2 Bio Partners III GP Limited
- Latest Form D
- May 6, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about K2 Bio Partners III L.P.
What is the minimum investment for K2 Bio Partners III L.P.?
K2 Bio Partners III L.P.'s latest Form D, filed May 6, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in K2 Bio Partners III L.P.?
K2 Bio Partners III L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has K2 Bio Partners III L.P. raised?
K2 Bio Partners III L.P. reports $30,500,000 sold from 3 investors on its Form D filed May 6, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is K2 Bio Partners III L.P. based?
K2 Bio Partners III L.P. is based in Grand Cayman, Cayman Islands.
When did K2 Bio Partners III L.P. launch?
K2 Bio Partners III L.P. reports its first sale in Apr 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every venture capital fund
Raised more than 82% of the 78 venture capital funds based in Cayman Islands, and more than 94% of all 15,180 that report sales.